SUBACUTE CUTANEOUS LUPUS ERYTHEMATOSUS
Clinical trials for SUBACUTE CUTANEOUS LUPUS ERYTHEMATOSUS explained in plain language.
Never miss a new study
Get alerted when new SUBACUTE CUTANEOUS LUPUS ERYTHEMATOSUS trials appear
Sign up with your email to follow new studies for SUBACUTE CUTANEOUS LUPUS ERYTHEMATOSUS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New injection tested for stubborn skin lupus rash
Disease control Recruiting nowThis study is testing an investigational medicine called IMVT-1402 for people with active skin lupus (cutaneous lupus erythematosus). Participants will receive weekly injections of either the study medicine or a placebo for 12 weeks, followed by longer treatment periods. The main…
Matched conditions: SUBACUTE CUTANEOUS LUPUS ERYTHEMATOSUS
Phase: PHASE2 • Sponsor: Immunovant Sciences GmbH • Aim: Disease control
Last updated Apr 04, 2026 06:34 UTC
-
New drug trial targets stubborn lupus skin rash
Disease control Recruiting nowThis study is testing an investigational drug called litifilimab for people with active skin lupus (cutaneous lupus) who haven't gotten better with standard antimalarial therapy. About 450 participants will receive either the drug or a placebo via injection every four weeks for 2…
Matched conditions: SUBACUTE CUTANEOUS LUPUS ERYTHEMATOSUS
Phase: PHASE2, PHASE3 • Sponsor: Biogen • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC